Geron reported $120.44M in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Amgen USD 51.61B 250M Sep/2026
Bio Techne USD 200M 0 Jun/2026
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 244.33M 3.87M Sep/2026
Genmab DKK 4.96B 28M Jun/2026
Geron USD 120.44M 308K Sep/2026
Gilead Sciences USD 23.82B 17M Sep/2026
Incyte USD 28.42M 994K Jun/2026
MacroGenics USD 163.16M 94.44M Jun/2026
Novartis USD 38.38B 893M Sep/2026
Novavax USD 246.3M 200K Dec/2025